SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001176256-08-000791
Filing Date
2008-06-17
Accepted
2008-06-17 18:53:39
Documents
1
Period of Report
2008-06-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5455
  Complete submission text file 0001176256-08-000791.txt   7431
Mailing Address 1727 WEST BROADWAY SUITE 400 VANCOUVER A1 V6J 4S5
Business Address 1727 WEST BROADWAY SUITE 400 VANCOUVER A1 V6J 4S5 604-738-6644
CHEMOKINE THERAPEUTICS CORP (Issuer) CIK: 0001092959 (see all company filings)

IRS No.: 330921251 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 2236 EAST MALL, SUITE 208 UNIVERSITY OF BRITISH COLUMBIA VANCOUVER A1 V6T 1Z3
Business Address (604) 822-0304
Salari Hassan (Reporting) CIK: 0001294506 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51080 | Film No.: 08904277